The prescription of ACE inhibitors or angiotensin receptor blockers should be with caution in patients with cardiovascular disease as these medications can upregulate ACE2 and potentially aggravate the patient’s health outcome [20,21]. This evidence concerns the gene ACE2 and cardiovascular disorder.